drugset
drugset / Trial / NCT04343222

Control of Pain in Intravitreal Injections Using Topical NSAIDs

NCT04343222 ↗

Phase 4 Completed 46 enrolled University of Wisconsin, Madison
RandomizedParallel-groupDouble-blindSupportive care

Summary

Intravitreal injections (IVI) are a common form of treatment for multiple retinal pathologies. The investigators hypothesize that an intervention with a topical NSAID will alleviate pain experienced at intravitreal injection (IVI) and post-IVI. 46 participants will be recruited, randomized into 1 of 3 treatment arms, and can expect to be on study for a day.

Timeline

Start
2019-06-27
Primary completion
2019-12-19
Completion
2019-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified 0.09 % Topical

Indications

No indication recorded.